Clinical Trial

RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China

Study acronym: RAISE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter, prospective, observational, community-based study designed to evaluate the incidence of respiratory syncytial virus (RSV) infection among community-dwelling elderly individuals in China, as well as their cohabiting older adults and children, over a 24-month period. During the study, home visits will be conducted to collect nasopharyngeal (NP) swabs from all community residents aged ≥50 years who report symptoms of acute respiratory infection (ARI). Pathogen detection will be performed using both point-of-care testing (POCT) and centralized laboratory analysis.
Trial Details
NCT Number NCT07075029
Lead Sponsor Huashan Hospital
Collaborators: Shanghai Huashen Institute of Microbes and Infections
Conditions Acute Respiratory Infections (ARIs)
Enrollment 28,800 participants
Start Date 2025-09-01
Primary Completion 2027-11-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-20